CLCS
Cell Source, Inc.
Key Financials
Net Income
$-5321212
↓ 3.0%
Operating Income
$-4325346
↓ 3.6%
EPS (Diluted)
$-0.17
↑ 5.6%
Total Assets
$195171.00
↓ 52.4%
Total Liabilities
$15.8M
↑ 21.2%
Shareholders' Equity
$-15611543.00
↓ 23.6%
Long-term Debt
$50000.00
N/A
Cash & Equivalents
$222665.00
↑ 139.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CLCS |
| Company Name | Cell Source, Inc. |
| CIK | 1569340 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 646-612-7554 |